Document is current

Any future updates will be listed below

Use of Nuclear Factor Erythroid 2-Eelated Factor Activators as A Strategy to Improve the Side Effects of COVID-19

Crossref DOI link: https://doi.org/10.32598/jams.24.5.2809.2

Published Online: 2021-12-01

Update policy: https://doi.org/10.32598/nsp.crossmark-policy

About CrossMark